While studies have reported elevated expression levels of miR-7974 in breast cancer [25] and colorectal cancer cells [26], suggesting a potential oncogenic function, contrasting evidence has demonstrated its downregulation in SHG-8- treated glioblastoma samples, which target the oncogenes CORO2A, APC2, and WNT7A [27]. This evidence concerns the gene CORO2A and colorectal cancer.